Literature DB >> 3020114

Effects of beta non-selective and beta 1 selective adrenergic blocking agents on glucagon secretion from isolated perfused rat pancreas.

F Gregorio, P Filipponi, S Cristallini, C Carloni, I Moretti, C Ferrandina, R Pippi, M Pietropaolo.   

Abstract

To characterize beta-receptors which affect pancreatic A-cell activity, the effects of propranolol (beta non-selective blockade) and metoprolol (beta 1 selective blockade) were evaluated on epinephrine modulated insulin (IRI) and glucagon (IRG) release both in basal state and during metabolic stimulus (arginine 20 mM). The isolated perfused rat pancreas model with the exclusion of stomach and duodenum was used. Epinephrine infusion (at 10(-7) M) caused a prompt and sustained increase in basal IRG secretion and significantly potentiated glucagon release in response to metabolic stimulus. Insulin secretion was markedly suppressed by epinephrine both in basal conditions and during metabolic stimulus. Propranolol (at 10(-7) M) and metoprolol (at 10(-7) M) infusion clearly and similarly counteracted epinephrine stimulatory effects on IRG secretion but failed to elicit any significant effect on the epinephrine inhibited IRI release either in basal state or during the metabolic stimulus. These results suggest that, at least in the rat, the adrenergic stimulation of IRG release is mediated through a beta 1 receptor.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3020114     DOI: 10.1007/bf03348100

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  31 in total

1.  Metabolic responses to selective beta-adrenergic stimulation in man.

Authors:  R Goldberg; M van As; B I Joffe; L Krut; I Bersohn; H C Seftel
Journal:  Postgrad Med J       Date:  1975-02       Impact factor: 2.401

2.  Discrepancies in the response of the insulin secreting cells of the dog and rat to different adrenergic stimulating agents.

Authors:  M M Loubatières-Mariani; J Chapal; G Ribes; A L Loubatières
Journal:  Acta Diabetol Lat       Date:  1977 May-Aug

3.  Metabolic effects of salbutamol infusion during premature labour.

Authors:  D J Thomas; A F Dove; K G Alberti
Journal:  Br J Obstet Gynaecol       Date:  1977-07

4.  Coated charcoal immunoassay of insulin.

Authors:  V Herbert; K S Lau; C W Gottlieb; S J Bleicher
Journal:  J Clin Endocrinol Metab       Date:  1965-10       Impact factor: 5.958

5.  Comparison of hormonal and metabolic effects of salbutamol infusion in normal subjects and insulin-requiring diabetics.

Authors:  A S Gündogdu; P M Brown; S Juul; L Sachs; P H Sönksen
Journal:  Lancet       Date:  1979 Dec 22-29       Impact factor: 79.321

6.  Characterization of adrenergic control of glucagon secretion from isolated perfused rat pancreas.

Authors:  P Filipponi; M Marcelli; I Nicoletti; R Pacifici; F Santeusanio; P Brunetti
Journal:  Diabete Metab       Date:  1982-12

7.  Physiological and pharmacological aspects of adrenergic receptor classification.

Authors:  E J Ariëns; A M Simonis
Journal:  Biochem Pharmacol       Date:  1983-05-15       Impact factor: 5.858

8.  Effects of nonselective and beta-1-selective blockade on glucose metabolism and hormone responses during insulin-induced hypoglycemia in normal man.

Authors:  U B Lauridsen; N J Christensen; J Lyngsøe
Journal:  J Clin Endocrinol Metab       Date:  1983-05       Impact factor: 5.958

9.  Effect of beta-blockade on hormone release during hypoglycaemia in insulin-dependent diabetics.

Authors:  I Lager; R Jagenburg; H von Schenck; U Smith
Journal:  Acta Endocrinol (Copenh)       Date:  1980-11

10.  Xylazine-induced hyperglycemia in cattle: a possible involvement of alpha 2-adrenergic receptors regulating insulin release.

Authors:  W H Hsu; S K Hummel
Journal:  Endocrinology       Date:  1981-09       Impact factor: 4.736

View more
  1 in total

1.  Effect of lithium on plasma glucose, insulin and glucagon in normal and streptozotocin-diabetic rats: role of glucagon in the hyperglycaemic response.

Authors:  O G Hermida; T Fontela; M Ghiglione; L O Uttenthal
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.